IFPAC®-2017 31st International Forum & Exhibition
31 October 2016 | By IFPAC
Emerging technologies to modernize pharmaceutical/biopharmaceutical development and manufacturing...
List view / Grid view
News
Yusen Logistics assists Boeing with hurricane Matthew relief aid
Yusen Logistics (Americas) Inc. has been recognized by the Boeing Co. for its role in coordinating shipments of relief supplies from Seattle, WA to Charleston, SC, to support Boeing employees and the local community recovering from the effects of Hurricane Matthew.
Coulter Partners builds presence in DACH region
31 October 2016 | By Coulter Partners
Global Life Sciences search specialist, Coulter Partners continues to grow its business in Germany, Switzerland and Austria in response to strong market growth in the region...
Novartis wins “Discovery of the Decade” and “Best Biotechnology Product” awards
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Novartis has been awarded the 2016 Prix Galien USA Award "Discovery of the Decade" Award for Best Pharmaceutical Product for the drug Gleevec, as well as...
Alprolix approved in Switzerland for the treatment of haemophilia B
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The Swiss Agency for Therapeutic Products, Swissmedic, has approved Alprolix (eftrenonacog alfa) for the treatment of haemophilia B...
FDA approves Roche’s immunotherapy assay to support treatment decisions in lung cancer
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The US Food and Drug Administration (FDA) has approved Roche’s PD-L1 assay as a diagnostic to identify PD-L1 expression levels in patients considering treatment with Tecentriq (atezolizumab) for previously treated metastatic non-small cell lung cancer (NSCLC). The PD-L1 (SP142) assay is also indicated to identify patients with urothelial cancer (UC)…
ESP & GS1 Ireland Partner to Improve Biopharmaceutical Anti-Counterfeiting Solutions
28 October 2016 | By ESP
Enterprise System Partners (ESP) has formally signed a partnership agreement with GS1 Ireland to work collaboratively in the development and delivery of the highest anti-counterfeiting solutions based on GS1 standards to the biopharmaceutical manufacturing industry...
ESP GS1 Ireland Serialisation Industry Readiness Report 2016
28 October 2016 | By ESP
In collaboration with our partners GS1 Ireland, ESP carried out an extensive industry survey to establish the status of the industry in relation to the impending serialisation deadlines, which are facing us in the coming months and years...
Airside Pharma Transport at Brussels Airport is European first
28 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Brussels Airport presented a European first at the TIACA Air Cargo Forum in Paris: the active version of the "Airside Pharma Transporter"...
Allergan acquires Motus following positive diabetic gastroparesis trial
28 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Results of a Phase 2b trial of relamorelin, Motus' ghrelin agonist, for the treatment of gastroparesis in diabetics has led to Allergan acquiring Motus...
Dolomite Bio offers flexible single cell encapsulation for autoimmune disease research
28 October 2016 | By Dolomite Bio
Dolomite Bio’s Single Cell RNA-Seq System is helping researchers at the University of Helsinki to investigate autoimmune diseases. Focusing on gastrointestinal conditions – such as coeliac disease and inflammatory bowel disease – the Molecular Genetics of Immunological Diseases group is using the system to study T-cell activation and response at…
Immune receives FDA guidance for acute myeloid leukaemia Phase III trial
28 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The proposed phase III study design reviewed by the FDA guidance focuses on overall survival as the primary endpoint, including Leukaemia Free Survival...
ObsEva Phase II trial shows meaningful increase in pregnancy and live birth rates
28 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The results of ObsEva’s trial of OBE001 (nolasiban) showed improvement in clinical pregnancy and live birth rates in women undergoing embryo transfer...
Martindale’s epilepsy oral suspension product approved in 7 European countries
27 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Clobazam oral suspension is used principally as an adjunctive therapy for epilepsy with the formulation particularly suitable for children and young adults...
First patient recruited for Phase III Japanese acute respiratory distress syndrome trial
27 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The Japanese Phase III clinical trial is a double-blinded, randomised, parallel-group comparison of efficacy and safety of FP-1201-lyo against placebo...
